264 related articles for article (PubMed ID: 24564001)
1. Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter?
DiNicolantonio JJ; Meier P; O'Keefe JH
Mo Med; 2013; 110(6):495-8. PubMed ID: 24564001
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids from fish oils and cardiovascular disease.
Holub DJ; Holub BJ
Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
Siscovick DS; Barringer TA; Fretts AM; Wu JH; Lichtenstein AH; Costello RB; Kris-Etherton PM; Jacobson TA; Engler MB; Alger HM; Appel LJ; Mozaffarian D;
Circulation; 2017 Apr; 135(15):e867-e884. PubMed ID: 28289069
[TBL] [Abstract][Full Text] [Related]
4. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
5. Do we need 'new' omega-3 polyunsaturated fatty acids formulations?
Cicero AF; Morbini M; Borghi C
Expert Opin Pharmacother; 2015 Feb; 16(3):285-8. PubMed ID: 25474717
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
7. Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies.
Tummala R; Ghosh RK; Jain V; Devanabanda AR; Bandyopadhyay D; Deedwania P; Aronow WS
Am J Med; 2019 Oct; 132(10):1153-1159. PubMed ID: 31077653
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie CJ; Milani RV; Mehra MR; Ventura HO
J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
[TBL] [Abstract][Full Text] [Related]
9. n-3 polyunsaturated fatty acids and cardiovascular diseases.
Nordøy A; Marchioli R; Arnesen H; Videbaek J
Lipids; 2001; 36 Suppl():S127-9. PubMed ID: 11837986
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future.
Watanabe Y; Tatsuno I
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):865-873. PubMed ID: 28531360
[TBL] [Abstract][Full Text] [Related]
11. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.
Wang C; Harris WS; Chung M; Lichtenstein AH; Balk EM; Kupelnick B; Jordan HS; Lau J
Am J Clin Nutr; 2006 Jul; 84(1):5-17. PubMed ID: 16825676
[TBL] [Abstract][Full Text] [Related]
12. Sea Change for Marine Omega-3s: Randomized Trials Show Fish Oil Reduces Cardiovascular Events.
O'Keefe EL; Harris WS; DiNicolantonio JJ; Elagizi A; Milani RV; Lavie CJ; O'Keefe JH
Mayo Clin Proc; 2019 Dec; 94(12):2524-2533. PubMed ID: 31627938
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular benefits of omega-3 fatty acids.
von Schacky C; Harris WS
Cardiovasc Res; 2007 Jan; 73(2):310-5. PubMed ID: 16979604
[TBL] [Abstract][Full Text] [Related]
15. Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease--eat fish or take fish oil supplement?
He K
Prog Cardiovasc Dis; 2009; 52(2):95-114. PubMed ID: 19732603
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
Holub BJ
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
[TBL] [Abstract][Full Text] [Related]
17. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acids: cardiovascular benefits, sources and sustainability.
Lee JH; O'Keefe JH; Lavie CJ; Harris WS
Nat Rev Cardiol; 2009 Dec; 6(12):753-8. PubMed ID: 19859067
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease and omega-3s: Prescription products and fish oil dietary supplements are not the same.
Gutstein AS; Copple T
J Am Assoc Nurse Pract; 2017 Dec; 29(12):791-801. PubMed ID: 29280361
[TBL] [Abstract][Full Text] [Related]
20. Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
Wen YT; Dai JH; Gao Q
Nutr Metab Cardiovasc Dis; 2014 May; 24(5):470-5. PubMed ID: 24472636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
